3 Point Analysis | Rossari Biotech's stellar listing: What should investors do now? - Moneycontrol.com 25-Jul-2020

on

3 Point Analysis | Rossari Biotech's stellar listing: What should investors do now? - Moneycontrol.com


The stock opened with a premium of Rs 245, or 58 percent, on the BSE against its issue price of Rs 425 per share, and rose to Rs 710 intraday, i.e. 67.1 percent higher

More...